pharma news today obesity glp-1 Eli Lilly pill Foundayo gets the FDA green light : NPR Drugmaker Eli Lilly announced that

This precision neurology approach, leveraging the unique insights from circRNA, is critical to facilitating early diagnosis and treatment for Alzheimers. Trontinemab, a disease-modifying drug designed to rapidly clear amyloid plaques from the brain, is moving ahead into Phase III trials

However, modern medical advances offer promising solutions for significantly reducing their appearance and preventing new ones from forming

Clostridium butyricum adds the postbiotic butyrate known to stimulate GLP-1 while Bifidobacterium infantis produces acetate and lactate to nourish beneficial bacteria such as Akkermansia and Butyricum promoting a balanced and healthy gut ecosystem

monitor patients for the emergence or worsening of depression, suicidal thoughts or behavior, and any unusual changes in moods or behaviors